IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India

por Verma, R., Ranadive, R., Kalra, S., Lathia, T., Saraf, A., Thakur, S., Sarwate, A., Lakhani, O., Das, R., Shenoy, M.T., Joshi, S., Singal, A.
Publicado 2022

Abstract 140: Significant reduction in HbA1c levels among participants with poorly controlled type 2 diabetes on diabefly(®) digital therapeutics program using multidisciplinary ap...

por Singal, Chitra Selvan Arbinder, Khader, Mohammed Abdul, Verma, Ritika, Kalra, Sanjay, Samudra, Kirti, Thakkar, Piya Ballani, Lakhani, O M, Thakur, Santosh, Shinde, Jaydeep, Chitnis, Nikhil, Kothari, Sneha, Joshi, Shilpa
Publicado 2022